Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer’s disease: a community based follow up study

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Neurology Neurosurgery & Psychiatry

• Publication date

  1998-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/jnnp.64.3.298PMID 9527138PMCID PMC2170016
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic accuracy of alzheimer’s disease: A neuropathological study

  2009cited by this paper
• Diagnostic accuracy of Alzheimer’s disease: A clinicopathological study

  2009cited by this paper
• Synaptic pathology in Alzheimer's disease: Relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele

  2005cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease

  1997cited by this paper
• Apolipoprotein-E genotyping in diagnosis of Alzheimer's disease.

  1996cited by this paper
• Apolipoprotein-E genotyping in diagnosis of Alzheimer's disease.

  1996cited by this paper
• Cerebrospinal protein tau is elevated in early Alzheimer's disease.

  1996cited by this paper
• Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease.

  1996cited by this paper
• Total tau protein immunoreactivity in lumbar cerebrospinal fluid of patients with Alzheimer's disease.

  1996cited by this paper
• Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

  1995cited by this paper
• Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis.

  1995cited by this paper
• Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type.

  1995cited by this paper
• Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease

  1995cited by this paper
• Tau protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's disease.

  1995cited by this paper
• Increased cerebrospinal fluid tau in patients with Alzheimer's disease.

  1995cited by this paper
• Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

  1995cited by this paper
• A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele.

  1995cited by this paper
• Cerebrospinal fluid levels of amyloid beta-protein in Alzheimer's disease: inverse correlation with severity of dementia and effect of apolipoprotein E genotype.

  1995cited by this paper
• Tau in cerebrospinal fluid: A potential diagnostic marker in Alzheimer's disease

  1995cited by this paper
• Tau in cerebrospinal fluids: establishment of the sandwich ELISA with antibody specific to the repeat sequence in tau.

  1995cited by this paper
• Increased levels of τ protein in cerebrospinal fluid of patients with alzheimer's disease—correlation with degree of cognitive impairment

  1995cited by this paper
• ApoE3 binding to tau tandem repeat I is abolished by tau serine262 phosphorylation.

  1995cited by this paper
• Clinical characteristics of rapidly progressive leuko‐araiosis

  1995cited by this paper
• Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease

  1995cited by this paper
• Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.

  1994cited by this paper
• Hypothesis: Microtubule Instability and Paired Helical Filament Formation in the Alzheimer Disease Brain Are Related to Apolipoprotein E Genotype

  1994cited by this paper
• Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.

  1993cited by this paper
• Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay.

  1993cited by this paper
• Apolipoprotein E polymorphism and Alzheimer's disease.

  1993cited by this paper
• Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

  1993cited by this paper
• New criteria for the diagnosis of vascular dementia

  1993cited by this paper
• Vascular dementia

  1993cited by this paper
• Tau Protein and the Neurofibrillary Pathology of Alzheimer's Disease

  1993cited by this paper
• Detection of Proteins in Normal and Alzheimer's Disease Cerebrospinal Fluid with a Sensitive Sandwich Enzyme‐Linked Immunosorbent Assay

  1993cited by this paper
• Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

  1993cited by this paper
• Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid.

  1992cited by this paper
• Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

  1992cited by this paper
• Pathogenetic basis of vascular dementia.

  1991cited by this paper
• Index to authors

  1991cited by this paper
• Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

  1991cited by this paper
• Abnormal phosphorylation of the microtubule-associated protein? (tau) in Alzheimer cytoskeletal pathology

  1987cited by this paper
• Neuron numbers and dendritic extent in normal aging and Alzheimer's disease.

  1987cited by this paper
• Neuron numbers and dendritic extent in normal aging and alzheimer's disease

  1987cited by this paper
• Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease.

  1986cited by this paper
• Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

  1986cited by this paper
• A Method for the Identification of Apolipoprotein E Isoforms Employing Chemical Precipitation and Flat Bed Isoelectric Focusing in Agarose

  1986cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Statistical guidelines for contributors to medical journals.

  1983cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• diagnostic and statistical manual of mental disorders,

  year unknowncited by this paper

• Risk of Developing Alzheimer Disease in Relation to Common Infections

  2025cites this paper
• Galectin-9 activates the TLR4-NLRP3 inflammasome pathway and promotes tau pathology in Alzheimer's disease.

  2025cites this paper
• Proposed mechanisms of tau: relationships to traumatic brain injury, Alzheimer’s disease, and epilepsy

  2024cites this paper
• Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

  2024cites this paper
• Non-Invasive Nasal Discharge Fluid and Other Body Fluid Biomarkers in Alzheimer’s Disease

  2022cites this paper
• Forensic biomarkers of lethal traumatic brain injury

  2022cites this paper
• PBPK-PD modeling for the preclinical development and clinical translation of tau antibodies for Alzheimer’s disease

  2022cites this paper
• Genetic and Transcriptomic Biomarkers in Neurodegenerative Diseases: Current Situation and the Road Ahead

  2021influential citation
• Bridging the Gap Between Fluid Biomarkers for Alzheimer’s Disease, Model Systems, and Patients

  2020cites this paper
• Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease

  2020cites this paper
• Artificial Intelligence for Medical Image Analysis of NeuroImaging Data

  2020cites this paper
• A deep belief network-based method to identify proteomic risk markers for Alzheimer disease

  2020cites this paper
• Biomarkers of Parkinson’s disease: 20 years later

  2019cites this paper
• Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

  2019cites this paper
• Biomarker in der Diagnostik und Differentialdiagnostik der vaskulären Demenz bei zerebraler Mikroangiopathie

  2019cites this paper
• Correlations Between Cerebrospinal Fluid Biomarkers Concentration and Severity of Cognitive Impairment in Alzheimer Disease

  2019cites this paper
• Prediction and Classification of Alzheimer’s Disease Based on Combined Features From Apolipoprotein-E Genotype, Cerebrospinal Fluid, MR, and FDG-PET Imaging Biomarkers

  2019cites this paper
• Biomarkers of Alzheimer's Disease

  2019cites this paper
• White matter abnormalities and cognition in patients with conflicting diagnoses and CSF profiles

  2018cites this paper
• Evaluation of cerebrospinal fluid phosphorylated tau231 as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia

  2018cites this paper
• Tau Protein as a Biological Fluid Biomarker in Neurodegenerative Dementias

  2018cites this paper
• Dynamics of proteinopathies in Alzheimer’s disease as measured by PET and CSF biomarkers

  2018cites this paper
• Amyloid beta and tau proteins in Alzheimer’s disease and Down syndrome

  2018cites this paper
• Salivary biomarkers for the diagnosis and monitoring of neurological diseases

  2018cites this paper
• CSF biomarkers are differentially related to structural and functional changes in dementia of the Alzheimer’s type

  2018cites this paper
• Detection of Aggregation-Competent Tau in Neuron-Derived Extracellular Vesicles

  2018cites this paper
• Cerebrospinal Fluid Biomarkers are Differentially Related to Structural and Functional Changes in Dementia of the Alzheimer’s Type

  2018cites this paper
• Learnings about the complexity of extracellular tau aid development of a blood‐based screen for Alzheimer's disease

  2018cites this paper
• Update on Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease

  2018cites this paper
• Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report

  2017cites this paper
• Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer’s disease

  2017cites this paper
• Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Show Different but Partially Overlapping Profile Compared to Vascular Dementia

  2017influential citation
• Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer’s Disease

  2017cites this paper
• Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibition

  2017cites this paper
• Cerebrospinal Fluid Biomarker-Based Diagnosis of Sporadic Creutzfeldt-Jakob Disease: A Validation Study for Previously Established Cutoffs

  2017cites this paper
• iTRAQ-based Proteomic Analysis of APPSw,Ind Mice Provides Insights into the Early Changes in Alzheimer’s Disease

  2017cites this paper
• A Systematic Review of Longitudinal Studies Which Measure Alzheimer’s Disease Biomarkers

  2017cites this paper
• Analytical performance of reagent for assaying tau protein in human plasma and feasibility study screening neurodegenerative diseases

  2017cites this paper
• GENETIC DISORDER ALZHEIMER

  2017cites this paper
• THE DEFAULT MODE NETWORK AND EXECUTIVE FUNCTION: INFLUENCE OF AGE, WHITE MATTER CONNECTIVITY, AND ALZHEIMER’S PATHOLOGY

  2017cites this paper
• Can microbiota research change our understanding of neurodegenerative diseases?

  2016cites this paper
• CSF biomarkers in neurodegenerative and vascular dementias.

  2016cites this paper
• Fingerprinting of Peptides with a Large Channel of Bacteriophage Phi29 DNA Packaging Motor.

  2016cites this paper
• How many biomarkers to discriminate neurodegenerative dementia?

  2015cites this paper
• Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer’s Disease Risk

  2015cites this paper
• Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia

  2015cites this paper
• New Frontiers in Alzheimer's Disease Diagnosis

  2015cites this paper
• Buccal cell cytokeratin 14 identifies mild cognitive impairment and Alzheimer' s disease in the AIBL study of aging.

  2015cites this paper
• Quantification of CSF biomarkers using an electrochemiluminescence-based detection system in the differential diagnosis of AD and sCJD

  2015cites this paper
• tau protein, ischemic injury and vascular dementia

  2015cites this paper
• Generation and diagnostic valorisation of monoclonal antibodies for human protein tau

  2014cites this paper
• Atividade antioxidante, anticolinesterásica e perfil metabolômico de diferentes tipos de pimentas: Implicações na doença de Alzheimer

  2014cites this paper
• NANOTECHNOLOGICAL ADVANCES TOWARDS ALZHEIMER'S DISEASE TREATMENT

  2014cites this paper
• Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease.

  2014cites this paper
• Cognitive erosion and its implications in Alzheimer’s disease

  2013cites this paper
• Longitudinal Stability of Cerebrospinal Fluid Biomarker Levels: Fulfilled Requirement for Pharmacodynamic Markers in Alzheimer's Disease

  2013cites this paper
• Cerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly.

  2013cites this paper
• Cerebrospinal fluid biomarkers for neurodegenerative disorders

  2013cites this paper
• A new decision tree combining Abeta 1-42 and p-Tau levels in Alzheimer's diagnosis.

  2013cites this paper
• Cerebrospinal fluid tau protein as a biomarker for severity of spinal cord injury in dogs with intervertebral disc herniation.

  2013cites this paper
• Longitudinal Cerebrospinal Fluid Biomarkers over Four Years in Mild Cognitive Impairment

  2012cites this paper
• Biomarkers for Alzheimer Disease in Cerebrospinal Fluid, Urine, and Blood

  2012cites this paper
• FTDP-17-typische frontale Verhaltensänderungen bei R406W-Tau transgenen Mäusen

  2012cites this paper
• Issues for Clinical Drug Development in Neurodegenerative Diseases

  2012cites this paper
• A Review of Biochemical Markers for Early Diagnosis of Alzheimer’s Disease

  2012cites this paper
• Cerebrospinal Fluid Biomarkers and Proximity to Diagnosis in Preclinical Familial Alzheimer’s Disease

  2012cites this paper
• The diagnosis and evaluation of dementia and mild cognitive impairment with emphasis on SPECT perfusion neuroimaging

  2012cites this paper
• Identification of Novel Fluid Biomarkers for Alzheimer's Disease

  2012cites this paper
• CSF tau and amyloid β42 levels in Alzheimer’s disease—A meta-analysis

  2012cites this paper
• Tau and p-tau as CSF biomarkers in dementia: a meta-analysis

  2011cites this paper
• Alzheimers Disease: Comprehensive Review of Aetiology, Diagnosis, Assessment Recommendations and Treatment.

  2011cites this paper
• [Biomarkers in spinal fluid of patients with dementia].

  2011cites this paper
• Longitudinal Changes of CSF Biomarkers in Alzheimer's Disease

  2011cites this paper
• Fish-on-a-chip: a sensitive detection microfluidic system for alzheimer's disease

  2011influential citation
• Age‐ and sex‐related differences in extra‐hepatic low‐density lipoprotein receptor

  2011cites this paper
• Evolution of the diagnostic criteria for degenerative and cognitive disorders.

  2011cites this paper
• Diagnostic Utility of CSF Tau and Aβ 42 in Dementia: A Meta-Analysis

  2011cites this paper
• The dynamic marker hypothesis of Alzheimer's disease and its implications for clinical imaging.

  2011cites this paper
• CSF Biomarkers

  2010cites this paper
• Anti-inflammatory therapy and cerebrospinal fluid diagnosis in Alzheimer's disease.

  2010cites this paper
• Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults.

  2010cites this paper
• An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels.

  2010influential citation
• Analysis of human tau in cerebrospinal fluid.

  2010cites this paper
• Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment and Dementia

  2010cites this paper
• 2D DIGE of the cerebrospinal fluid proteome in neurological diseases

  2010cites this paper
• CSF Biomarkers Profile in CADASIL—A Model of Pure Vascular Dementia: Usefulness in Differential Diagnosis in the Dementia Disorder

  2010cites this paper
• Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity

  2010influential citation
• Development of a sensitive ELISA for quantification of three- and four-repeat tau isoforms in tauopathies.

  2009cites this paper
• Neurodegenerative Biomarkers in Healthy Elderly - with special reference to the preclinical pattern of biological and cognitive markers for Alzheimer’s disease

  2009cites this paper
• The validity of biomarkers as surrogate endpoints in Alzheimer's disease by means of the Quantitative Surrogate Validation Level of Evidence Scheme (QSVLES)

  2009cites this paper
• CSF biomarker profile and diagnostic value in vascular dementia

  2009cites this paper
• Cerebrospinal tau, phospho‐tau, and beta‐amyloid and neuropsychological functions in Parkinson's disease

  2009cites this paper
• The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease.

  2009cites this paper
• Biomarkers of Alzheimer's disease.

  2009cites this paper
• Biomarkers in the cerebrospinal fluid and neurodegeneration in Langerhans cell histiocytosis

  2009cites this paper
• Decreased cerebrospinal fluid Aβ42 correlates with brain atrophy in cognitively normal elderly

  2009cites this paper
• Validity of Cerebrospinal Fluid Biomarkers as Endpoints in Early-Phase Clinical Trials for Alzheimer's Disease

  2009cites this paper
• Subcortical Vascular Dementia Biomarker Pattern in Mild Cognitive Impairment

  2009cites this paper
• Research Article

  2009cites this paper
• Alzheimer’s Disease, Diagnosis and the Need for Biomarkers

  2008cites this paper